2nd International Conference on Fostering Interdisciplinary Research In Health Sciences (ICFIRHS) 2019 (01-May-2019)        |

Journal :   Research Journal of Pharmacy and Technology

Volume No. :   8

Issue No. :  12

Year :  2015

Pages :   1653-1661

ISSN Print :  0974-3618

ISSN Online :  0974-360X


Registration

Allready Registrered
Click to Login

Development and Validation of Novel RP-HPLC Method for Estimation of Bosentan in Pharmaceutical Dosage Forms



Address:   Oruganti Sai Koushik, V. Himaja, P. Srinivasa Babu, Ramadoss Karthikeyan*
Vignan Pharmacy College, Vadlamudi-522213 A.P. India.
*Corresponding Author
DOI No: 10.5958/0974-360X.2015.00298.X

ABSTRACT:
The aim of the present work was to develop and validate a simple, economical, efficient and method for the analysis of Bosentan in pharmaceutical dosage forms by reverse phase high pressure liquid chromatography. A Welchrom C-18 reverse phase column (4.6 x 250 mm, 5 µm). With mobile phase containing 10mM Phosphate Buffer (pH 6.0): Acetonitrile (50:50, v/v) is used and eluents were monitored at 226nm. The retention time of Bosentan was 3.687min. The method showed a good linearity in the concentration range of 15-27 µg/mL. The validation characteristics included specificity, linearity and limit of detection, limit of quantification, precision, robustness and stability. Validation acceptance criteria were met in all cases. The percent recoveries ranged between 90.7 – 100 and RSD 0.28%. The method could be successfully used for the analysis of Bosentan in pharmaceutical dosage forms
KEYWORDS:
Bosentan, RP-HPLC, Method development and Validation.
Cite:
Oruganti Sai Koushik, V. Himaja, P. Srinivasa Babu, Ramadoss Karthikeyan. Development and Validation of Novel RP-HPLC Method for Estimation of Bosentan in Pharmaceutical Dosage Forms. Research J. Pharm. and Tech. 8(12): Dec., 2015; Page 1653-1661.
[View HTML]      [View PDF]



Visitor's No. :   646836